Lenalidomide
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7216 publications
Advances in the management of myelodysplastic neoplasms
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 28, 2026
Multiple myeloma: an overview of drug therapies and supportive care.
Journal: Australian prescriber
Published: October 27, 2026
Vepdegestrant (ARV-471): pharmacokinetics, drug metabolism and clinical translation of an oral ERα-targeting PROTAC.
Journal: Expert opinion on drug metabolism & toxicology
Published: October 20, 2026
Real-world cost-effectiveness of sequential therapy of in-class transition to ixazomib versus daratumumab for transplant-ineligible newly diagnosed multiple myeloma in China.
Journal: Journal of comparative effectiveness research
Published: October 13, 2026
A tale of two triplets: tafasitamab or epcoritamab in combination with rituximab and lenalidomide in relapsed/refractory follicular lymphoma.
Journal: Expert opinion on biological therapy
Published: October 07, 2026
Venetoclax-based Therapy Improves Outcomes across the Evolving Biology of t(11;14) Multiple Myeloma.
Venetoclax-based Therapy Improves Outcomes across the Evolving Biology of t(11;14) Multiple Myeloma.
Journal: medRxiv : the preprint server for health sciences
Published: October 01, 2026
Lenalidomide-Associated Myocardial Injury Despite Nondiagnostic Cardiac Magnetic Resonance Imaging.
Journal: The Annals of pharmacotherapy
Published: September 30, 2026
Abemaciclib and lenalidomide presenting with central retinal artery occlusion in a patient with breast cancer and multiple myeloma: a possible treatment-related association.
Journal: BMJ case reports
Published: September 28, 2026
Expression Level and Function of UBE2QL1 in Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: September 28, 2026
Clinical Characteristics and Survival Analysis of Patients with IgD Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: September 28, 2026
Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Transplant-Ineligible Subgroup Analysis of CEPHEUS.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 25, 2026
A Case of Acute Lymphoblastic Leukemia Developing After a Diagnosis of Myelodysplastic Syndrome Following Lenalidomide Therapy for Multiple Myeloma.
Journal: Internal medicine (Tokyo, Japan)
Published: September 23, 2026
Last Updated: 11/08/2026